FCPA Docket: Bio-Rad’s GC whistleblower saga goes on
Credit: iStockphoto.com/fstop123
In today’s news round-up, a California pharmaceutical company is taking an unfair dismissal case to an appeals court, and the lower legislative body of Congress votes to reform the SEC’s whistleblower awards programme.
To read more
Subscribe to Global Investigations Review
Subscribe and start reading now
Global Investigations Review (GIR) is the hub for global coverage of corporate investigations and their aftermath. Keep up to date with significant developments in the corporate investigations world.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10